Pfizer has agreed to pay the U.S. government $23.85 million to resolve allegations that it used a charitable foundation as a conduit to pay out-of-pocket copayments required of Medicare patients taking three Pfizer drugs. The U.S. Department of Justice said the settlement resolves allegations resulting from an industry-wide probe of unlawful business practices led by Massachusetts U.S. Attorney Andrew Lelling. According to federal prosecutors, Pfizer worked with the Patient Access Network Foundation to cover the copayments of Medicare beneficiaries taking Pfizer’s kidney cancer drugs Sutent and Inlyta and its heart drug Tikosyn. The federal Anti-Kickback Statute and False Claims Act ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.